Literature DB >> 25085748

A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism.

Gul Yalcin-Cakmakli1, Simone Olgiati2, Marialuisa Quadri2, Guido J Breedveld2, Pietro Cortelli3, Vincenzo Bonifati4, Bulent Elibol5.   

Abstract

Juvenile parkinsonism can be caused by recessive mutations in several genes. Among these, homozygous or compound heterozygous mutations in the F-box only protein 7 gene (FBXO7) cause juvenile parkinsonism with variable degrees of pyramidal disturbances (PARK15). So far, only five families (from Iran, Italy, The Netherlands, Pakistan, and Turkey) have been reported with this form. Here, we describe a new Turkish family with homozygous FBXO7 mutation (c.1492C > T, p.Arg498*). Three out of nine siblings born from consanguineous parents suffered from juvenile-onset progressive parkinsonism. Mental retardation was also documented in two of them. Of note, pyramidal signs were absent. The response to dopaminergic medications was present, but limited by dyskinesias and psychiatric side effects. Further genetic analysis of this Turkish family and the Italian PARK15 family reported previously revealed that the c.1492C > T mutation is present on two different haplotypes in the Italian family, and one of these haplotypes is shared in homozygous state in the Turkish patients. These findings contribute to the ongoing delineation of the genetic and clinical spectrum of PARK15.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  FBXO7; Gene; Juvenile; Mutation; Parkinsonism; Turkey

Mesh:

Substances:

Year:  2014        PMID: 25085748     DOI: 10.1016/j.parkreldis.2014.06.024

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  14 in total

1.  Chemical inhibition of FBXO7 reduces inflammation and confers neuroprotection by stabilizing the mitochondrial kinase PINK1.

Authors:  Yuan Liu; Travis B Lear; Manish Verma; Kent Zq Wang; P Anthony Otero; Alison C McKelvey; Sarah R Dunn; Erin Steer; Nicholas W Bateman; Christine Wu; Yu Jiang; Nathaniel M Weathington; Mauricio Rojas; Charleen T Chu; Bill B Chen; Rama K Mallampalli
Journal:  JCI Insight       Date:  2020-06-04

2.  Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.

Authors:  Siv Vingill; David Brockelt; Camille Lancelin; Lars Tatenhorst; Guergana Dontcheva; Christian Preisinger; Nicola Schwedhelm-Domeyer; Sabitha Joseph; Miso Mitkovski; Sandra Goebbels; Klaus-Armin Nave; Jörg B Schulz; Till Marquardt; Paul Lingor; Judith Stegmüller
Journal:  EMBO J       Date:  2016-08-05       Impact factor: 11.598

Review 3.  Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Authors:  Susanne A Schneider; Roy N Alcalay
Journal:  Mov Disord       Date:  2017-11       Impact factor: 10.338

4.  Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.

Authors:  Sabitha Joseph; Siv Vingill; Olaf Jahn; Robert Fledrich; Hauke B Werner; Istvan Katona; Wiebke Möbius; Mišo Mitkovski; Yuhao Huang; Joachim Weis; Michael W Sereda; Jörg B Schulz; Klaus-Armin Nave; Judith Stegmüller
Journal:  J Neurosci       Date:  2019-05-13       Impact factor: 6.167

5.  PINK1: Multiple mechanisms of neuroprotection.

Authors:  Britney N Lizama; P Anthony Otero; Charleen T Chu
Journal:  Int Rev Mov Disord       Date:  2021-10-04

Review 6.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

Review 7.  A Practical Approach to Early-Onset Parkinsonism.

Authors:  Giulietta M Riboldi; Emanuele Frattini; Edoardo Monfrini; Steven J Frucht; Alessio Di Fonzo
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

8.  Familial atypical parkinsonism with rare variant in VPS35 and FBXO7 genes: A case report.

Authors:  Tereza Bartonikova; Katerina Mensikova; Lenka Mikulicova; Radek Vodicka; Radek Vrtel; Marek Godava; Miroslav Vastik; Michaela Kaiserova; Pavel Otruba; Iva Dolinova; Martin Nevrly; Petr Kanovsky
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 9.  Ubiquitin and Parkinson's disease through the looking glass of genetics.

Authors:  Helen Walden; Miratul M K Muqit
Journal:  Biochem J       Date:  2017-04-13       Impact factor: 3.857

10.  Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect.

Authors:  Marta Correa-Vela; Vincenzo Lupo; Marta Montpeyó; Paula Sancho; Anna Marcé-Grau; Jorge Hernández-Vara; Alejandra Darling; Alison Jenkins; Sandra Fernández-Rodríguez; Cristina Tello; Laura Ramírez-Jiménez; Belén Pérez; Ángel Sánchez-Montáñez; Alfons Macaya; María J Sobrido; Marta Martinez-Vicente; Belén Pérez-Dueñas; Carmen Espinós
Journal:  Ann Clin Transl Neurol       Date:  2020-08-06       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.